Apollo, Kohlberg, Montagu pursue surgical equipment providers; Radiopharma boom aids Trilantic North America’s $945m SOFIE Biosciences exit

Published on October 9, 2026

Barriers to entry are an attractive driver for private equity firms that already have a sizeable presence in a sector, and we discuss the influence in two healthcare markets: surgical equipment providers and radiopharmaceuticals.

The post Apollo, Kohlberg, Montagu pursue surgical equipment providers; Radiopharma boom aids Trilantic North America’s $945m SOFIE Biosciences exit appeared first on PE Hub.